TGFB1 and viral infectious disease: Further establishing the effectiveness of tranilast in viral infection would support the use of TGF-β modulators for the prevention/treatment of GC insensitivity occurring during RSV infection-induced bronchiolitis or asthma/ COPD exacerbations.